{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:27:33Z","timestamp":1770884853789,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.msard.2025.106316","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:16:59Z","timestamp":1738714619000},"page":"106316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of COVID-19 and vaccination on multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD)"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6962-5541","authenticated-orcid":false,"given":"Metha","family":"Apiwattanakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chawarat","family":"Ounmuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8183-348X","authenticated-orcid":false,"given":"Saharat","family":"Aungsumart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106316_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102947","article-title":"Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? a retrospective study","volume":"52","author":"Barzegar","year":"2021","journal-title":"Mult. Scler Relat. Disord."},{"key":"10.1016\/j.msard.2025.106316_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.755333","article-title":"Multiple sclerosis and SARS-CoV-2: has the interplay started?","volume":"12","author":"Bellucci","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2025.106316_bib0004","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12883-022-02590-9","article-title":"Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? a cohort study","volume":"22","author":"Etemadifar","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2025.106316_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102915","article-title":"COVID-19 and the risk of relapse in multiple sclerosis patients: a fight with no bystander effect?","volume":"51","author":"Etemadifar","year":"2021","journal-title":"Mult. Scler Relat. Disord."},{"key":"10.1016\/j.msard.2025.106316_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107210","article-title":"SARS-CoV-2 triggered relapse of multiple sclerosis","volume":"215","author":"Finsterer","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"18","key":"10.1016\/j.msard.2025.106316_bib0007","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.msard.2025.106316_bib0008","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.msard.2025.106316_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577765","article-title":"A systematic review of cases of CNS demyelination following COVID-19 vaccination","volume":"362","author":"Ismail","year":"2022","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.msard.2025.106316_bib0010","first-page":"e17506","article-title":"Complications of COVID-19 pneumonia and multiple sclerosis exacerbation","volume":"13","author":"Jaisankar","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.msard.2025.106316_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104167","article-title":"Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"68","author":"Kong","year":"2022","journal-title":"Mult. Scler Relat. Disord."},{"key":"10.1016\/j.msard.2025.106316_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103697","article-title":"Post COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD): A case report-based systematic review","volume":"60","author":"Mirmosayyeb","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106316_bib0013","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jocn.2022.08.012","article-title":"Multiple sclerosis relapse after COVID-19 vaccination: a case report-based systematic review","volume":"104","author":"Nabizadeh","year":"2022","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.msard.2025.106316_bib0014","series-title":"Clinical Practice Guidelines: Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder","year":"2018"},{"issue":"3","key":"10.1016\/j.msard.2025.106316_bib0015","first-page":"596","article-title":"Multiple sclerosis risk factors and pathogenesis","volume":"25","author":"Nourbakhsh","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"issue":"4","key":"10.1016\/j.msard.2025.106316_bib0016","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/neurolint13040066","article-title":"Clinical Onset and Multiple sclerosis relapse after SARS-CoV-2 infection","volume":"13","author":"Pignolo","year":"2021","journal-title":"Neurol. Int."},{"key":"10.1016\/j.msard.2025.106316_bib0017","unstructured":"Ramadan, A., Osman, G., 2021. Neurological Care and the covid-19 Pandemic Elsevier - Health Sciences Division, Philadelphia, PA."},{"issue":"2","key":"10.1016\/j.msard.2025.106316_bib0018","first-page":"116","article-title":"Coronavirus disease 2019 (COVID-19) case report: the first case in Thailand and outside China","volume":"14","author":"Ratnarathorn","year":"2020","journal-title":"J. Bamrasnaradura Infect. Dis. Inst."},{"issue":"2","key":"10.1016\/j.msard.2025.106316_bib0019","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.msard.2025.106316_bib0020","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.msard.2025.106316_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.msard.2025.106316_bib0022","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMra1904655","article-title":"Neuromyelitis optica spectrum disorder","volume":"387","author":"Wingerchuk","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2025.106316_bib0023","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","volume":"87","author":"Wu","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.msard.2025.106316_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102947","article-title":"Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? a retrospective study","volume":"52","author":"Barzegar","year":"2021","journal-title":"Mult. Scler Relat. Disord."},{"key":"10.1016\/j.msard.2025.106316_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.755333","article-title":"Multiple sclerosis and SARS-CoV-2: has the interplay started?","volume":"12","author":"Bellucci","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.msard.2025.106316_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10060345","article-title":"COVID-19 immunopathology and the central nervous system: implication for multiple sclerosis and other autoimmune diseases with associated demyelination","volume":"10","author":"Boziki","year":"2020","journal-title":"Brain Sci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:48:52Z","timestamp":1741841332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":25,"alternative-id":["S2211034825000604"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106316","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of COVID-19 and vaccination on multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD)","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106316"}}